Why
would you say your work is highly cited?
|
“[My work] deals with scientifically and clinically relevant topics
and systemically addresses a void in the knowledge on ADHD and related disorders.”
|
|
Because it deals with scientifically and clinically relevant
topics and systematically addresses a void in the knowledge on ADHD
and related disorders.
What
are the circumstances which led you to your work?
The care of patients affected with this disorder and their
families and the need to understand the condition and how to best
treat it.
How
would you describe the significance of this work for your field?
My work helped redefine the way that ADHD is conceptualized all
over the world today as a highly morbid brain disorder affecting
males and females equally, of likely genetic etiology, and with
associated severe risk for psychiatric and cognitive comorbidity.
How
much has this research advanced since you first started publishing on
it?
Dramatically! Our work has helped to support the notion accepted
today that ADHD is a treatable, serious brain disorder of genetic
etiology associated with high levels of psychiatric and cognitive
comorbidity.
Where
do you see this research going 10 years from now?
We are expanding our work to include not only careful
longitudinal follow-ups of boys and girls with and without ADHD into
adult years but also adding all forms of neuroimaging (PET,
Spectroscopy, morphometric and functional MRI), genetic studies
(including pharmacogenetic studies), and neuropsychological studies
aimed at better defining and treating executive function deficits.
Our work is also expanding to the study of early temperamental
antecedents to ADHD in young preschool offspring of parents with
this disorder, intervention studies to include pharmacological and
psychotherapeutic modalities, as well as early intervention
strategies for children at risk for complicated course including
addictions to tobacco, alcohol, and drugs. Finally, our program will
have an increasingly greater focus in adult ADHD from all of the
above described perspectives.
Joseph Biederman, M
ccording to our Special Topics analysis of ADD/ADHD research over the past decade, the scientist with the most-cited research is Dr. Joseph Biederman, with 294 papers cited a total of 6,866 times to date. Dr. Biederman is a contributing author to five papers in this Topic’s list of most-cited papers from the past decade and the past two years. In the
Web product, Dr. Biederman’s work can be found in the field of Psychiatry/Psychology. Dr. Biederman is a Professor of Psychiatry at Harvard Medical School and Chief of the Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital in Boston. In the interview below, he talks about his highly cited work.
